Skip to content

Clinical trials

Glomerulonephritis, IGA trials in Malaysia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis, IGA Country / region: Malaysia Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20131
20181
20191
20201
20213
20224
20233
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting5
Active, not recruiting4
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Otsuka Pharmaceutical Development & Commercialization, Inc.3
The George Institute2
Alexion Pharmaceuticals, Inc.1
Alnylam Pharmaceuticals1
Anthera Pharmaceuticals1
Biogen1
Eledon Pharmaceuticals1
HI-Bio, A Biogen Company1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis, IGA20
Kidney Diseases7
Glomerulonephritis6
Renal Insufficiency, Chronic6
Proteinuria4
Urologic Diseases4
Autoimmune Diseases2
Immune System Diseases2
Kidney Failure, Chronic2
Nephritis2

Trials

Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.